Published in Clin Cancer Res on August 01, 1998
SU11248 inhibits tumor growth and CSF-1R-dependent osteolysis in an experimental breast cancer bone metastasis model. Clin Exp Metastasis (2003) 2.56
The macrophage colony-stimulating factor 1 response signature in breast carcinoma. Clin Cancer Res (2009) 2.00
Expression of colony-stimulating factor 1 receptor during prostate development and prostate cancer progression. Proc Natl Acad Sci U S A (2002) 1.40
Role of CSF-1 in progression of epithelial ovarian cancer. Future Oncol (2009) 1.07
The role of cytokines in breast cancer development and progression. J Interferon Cytokine Res (2014) 0.95
SGK1, a potential regulator of c-fms related breast cancer aggressiveness. Clin Exp Metastasis (2004) 0.92
The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. PLoS One (2011) 0.90
Autocrine CSF-1 and CSF-1 receptor coexpression promotes renal cell carcinoma growth. Cancer Res (2011) 0.86
Correlation of tumor phenotype with c-fms proto-oncogene expression in an in vivo intraperitoneal model for experimental human breast cancer metastasis. Clin Exp Metastasis (2005) 0.83
CSF1 is a novel p53 target gene whose protein product functions in a feed-forward manner to suppress apoptosis and enhance p53-mediated growth arrest. PLoS One (2013) 0.81
Chromatin-associated CSF-1R binds to the promoter of proliferation-related genes in breast cancer cells. Oncogene (2013) 0.80
Profiling Y561-dependent and -independent substrates of CSF-1R in epithelial cells. PLoS One (2010) 0.80
Identification of the uvrA gene product. J Mol Biol (1981) 8.35
Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis (1997) 4.66
The perpetuation of orthomyxoviruses and paramyxoviruses in Canadian waterfowl. Can J Microbiol (1980) 4.14
Insertional tagging, cloning, and expression of the Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyltransferase gene. Use as a selectable marker for stable transformation. J Biol Chem (1996) 4.06
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Multicenter evaluation of the AMPLICOR and automated COBAS AMPLICOR CT/NG tests for detection of Chlamydia trachomatis. J Clin Microbiol (2000) 3.44
Multicenter evaluation of AMPLICOR and automated COBAS AMPLICOR CT/NG tests for Neisseria gonorrhoeae. J Clin Microbiol (2000) 2.80
BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patients after lumpectomy and radiation therapy: implications for breast-conserving management in patients with BRCA1/BRCA2 mutations. J Clin Oncol (1999) 2.79
Violence victimization after HIV infection in a US probability sample of adult patients in primary care. Am J Public Health (2000) 2.75
Germination of Witchweed (Striga lutea Lour.): Isolation and Properties of a Potent Stimulant. Science (1966) 2.57
Treatment of carbon monoxide poisoning: a critical review of human outcome studies comparing normobaric oxygen with hyperbaric oxygen. Ann Emerg Med (1994) 2.42
Novel influenza A viruses isolated from Canadian feral ducks: including strains antigenically related to swine influenza (Hsw1N1) viruses. J Gen Virol (1978) 2.27
Wild ducks are the reservoir for only a limited number of influenza A subtypes. Epidemiol Infect (1993) 2.21
Circulation of influenza viruses and paramyxoviruses in waterfowl originating from two different areas of North America. Bull World Health Organ (1985) 2.18
Metastatic mature teratoma in lung following testicular embryonal carcinoma and teratocarcinoma. Arch Pathol Lab Med (1993) 2.16
Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis (1984) 2.11
Prevention of insect-borne disease: an approach using transgenic symbiotic bacteria. Proc Natl Acad Sci U S A (1997) 2.08
Water-bone transmission of influenza A viruses? Intervirology (1979) 2.04
Menkes' kinky-hair syndrome. Lancet (1972) 1.99
BAG-1: a novel biomarker predicting long-term survival in early-stage breast cancer. J Clin Oncol (2001) 1.97
X-linked mental retardation without physical abnormality: Renpenning's syndrome. Dev Med Child Neurol (1971) 1.95
Initial CT findings in 753 patients with severe head injury. A report from the NIH Traumatic Coma Data Bank. J Neurosurg (1990) 1.91
X-linked mental retardation. J Med Genet (1974) 1.91
Margins of "lumpectomy" for breast cancer. Hum Pathol (1986) 1.86
Adenoid cystic carcinoma: a retrospective clinical review. Int J Cancer (2001) 1.83
Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res (1997) 1.76
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
Enhancing the specificity of the COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae by retesting specimens with equivocal results. J Clin Microbiol (2001) 1.73
Uncommon high-risk lesions of the breast diagnosed at stereotactic core-needle biopsy: clinical importance. Radiology (2000) 1.72
Ductal lavage for detection of cellular atypia in women at high risk for breast cancer. J Natl Cancer Inst (2001) 1.68
Crystal structures of Toxoplasma gondii HGXPRTase reveal the catalytic role of a long flexible loop. Nat Struct Biol (1996) 1.66
X-linked mental retardation associated with macro-orchidism. J Med Genet (1975) 1.62
True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys (2000) 1.62
Postmastectomy radiotherapy: questions for the twenty-first century. J Clin Oncol (1998) 1.55
CT assessment of tumour response to treatment: comparison of linear, cross-sectional and volumetric measures of tumour size. Br J Radiol (2000) 1.55
Calcifications in axillary lymph nodes caused by fat necrosis. AJR Am J Roentgenol (1996) 1.54
Second malignancies after treatment of early-stage breast cancer: lumpectomy and radiation therapy versus mastectomy. J Clin Oncol (2000) 1.54
Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer (1983) 1.53
Brown-Séquard and his syndrome. Lancet (2000) 1.51
Single cell analysis of cytokine gene coexpression during CD4+ T-cell phenotype development. Proc Natl Acad Sci U S A (1995) 1.51
Mammographically detected, clinically occult ductal carcinoma in situ treated with breast-conserving surgery and definitive breast irradiation. Cancer J Sci Am (2006) 1.50
Breast-conserving therapy in the setting of collagen vascular disease. Cancer J (2001) 1.50
Smooth muscle releases an epithelial cell scatter factor which binds to heparin. In Vitro Cell Dev Biol (1989) 1.48
Isolation and characterization of an immortal neoplastic cell line (KS Y-1) from AIDS-associated Kaposi's sarcoma. J Natl Cancer Inst (1995) 1.46
Diabetes services in the UK: fourth national survey; are we meeting NSF standards and NICE guidelines? Arch Dis Child (2005) 1.45
Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer. Clin Cancer Res (2004) 1.44
Impact of non-CTCL dermatologic diagnoses and adjuvant therapies on cutaneous T-cell lymphoma patients treated with total skin electron beam radiation therapy. Int J Radiat Oncol Biol Phys (1994) 1.44
Mass spectrometric identification of mtb81, a novel serological marker for tuberculosis. J Clin Microbiol (2000) 1.44
Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res (1998) 1.44
Reproducibility of major diagnoses in a binational study of lung cancer in uranium miners and atomic bomb survivors. Am J Clin Pathol (1994) 1.42
Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium. EMBO J (1989) 1.40
The detection and treatment of early lung cancer. Ann Surg (1974) 1.39
Relationship between breast histopathology and family history of breast cancer. Cancer (1993) 1.38
Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res (1997) 1.35
Identification of the uvrC gene product. Proc Natl Acad Sci U S A (1981) 1.35
Antibodies to defined histone epitopes reveal variations in chromatin conformation and underacetylation of centric heterochromatin in human metaphase chromosomes. Chromosoma (1992) 1.33
An improved Knott's concentration test for the detection of microfilariae. Trans R Soc Trop Med Hyg (2000) 1.32
Scar cancers of the lung: origin and significance. Hum Pathol (1984) 1.31
Use of cancer susceptibility testing among primary care physicians. Clin Genet (2003) 1.30
Occult bronchogenic carcinoma. Endoscopic localization and television documentation. Cancer (1972) 1.26
Breast carcinoma in situ: risk factors and screening patterns. J Natl Cancer Inst (2001) 1.26
Risk of female breast cancer associated with serum polychlorinated biphenyls and 1,1-dichloro-2,2'-bis(p-chlorophenyl)ethylene. Cancer Epidemiol Biomarkers Prev (2000) 1.24
E. coli uvrB protein binds to DNA in the presence of uvrA protein. Nature (1981) 1.24
Ectopic pregnancy: duplex Doppler evaluation. Radiology (1989) 1.22
Evidence for a role for DNA polymerase beta in mammalian meiosis. Proc Natl Acad Sci U S A (1997) 1.22
Disarming the bluebottle: treatment of Physalia envenomation. Med J Aust (1980) 1.21
Independent regulation of invasion and anchorage-independent growth by different autophosphorylation sites of the macrophage colony-stimulating factor 1 receptor. Cancer Res (1996) 1.21
A general approach for purifying proteins encoded by cloned genes without using a functional assay: isolation of the uvrA gene product from radiolabeled maxicells. Nucleic Acids Res (1981) 1.20
Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol (2000) 1.19
The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med (1999) 1.18
Perceptions of academic vulnerability associated with personal illness: a study of 1,027 students at nine medical schools. Collaborative Research Group on Medical Student Health. Compr Psychiatry (2001) 1.18
Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1. Am J Pathol (1990) 1.18
Transforming growth factor beta type I receptor kinase mutant associated with metastatic breast cancer. Cancer Res (1998) 1.18
FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro. Oncogene (1991) 1.18
Roles of Fas and Fas ligand during mammary gland remodeling. J Clin Invest (2000) 1.18
Carcinoma in situ of the breast. Cancer (1977) 1.17
Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. FEBS Lett (2001) 1.17
Recurrence risk of mental retardation in sibs. Med J Aust (1971) 1.17
Ets-2 transdominant mutant abolishes anchorage-independent growth and macrophage colony-stimulating factor-stimulated invasion by BT20 breast carcinoma cells. Cancer Res (1998) 1.16
Ductal carcinoma in situ diagnosed with stereotactic core needle biopsy: can invasion be predicted? Radiology (2000) 1.15
Correlation of Doppler US tumor signals with neovascular morphologic features. Radiology (1988) 1.15
Spinal cord atrophy and disability in multiple sclerosis over four years: application of a reproducible automated technique in monitoring disease progression in a cohort of the interferon beta-1a (Rebif) treatment trial. J Neurol Neurosurg Psychiatry (2003) 1.15
Local recurrence in the conservatively treated breast cancer patient: a correlation with age and family history. Cancer J Sci Am (1998) 1.15
Tumor necrosis factor stimulates epithelial tumor cell motility. Cancer Res (1991) 1.14
X-linked mental retardation without physical abnormality (Renpenning's syndrome) in sibs in an institution. J Med Genet (1972) 1.13
Primary malignant melanoma of the lower respiratory tract. Report of a case and literature review. Am J Clin Pathol (1990) 1.12
IgD antibody to insuin. Lancet (1970) 1.12
Search for resistances controlling canine gastric emptying of liquid meals. Am J Physiol (1981) 1.12
Heterotopic epithelium in axillary lymph nodes: report of a case and review of the literature. Am J Clin Pathol (1973) 1.11
Underuse of primary Mycobacterium avium complex and Pneumocystis carinii prophylaxis in the United States. J Acquir Immune Defic Syndr (2001) 1.10
Expression of a functional antibody fragment in the gut of Rhodnius prolixus via transgenic bacterial symbiont Rhodococcus rhodnii. Med Vet Entomol (1999) 1.10
Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up. J Clin Oncol (2004) 1.10